Best Researcher Award

Hideomi Yamashita recognizes researchers whose sustained scholarly contributions demonstrate scientific excellence, research productivity, and measurable academic impact. Hideomi Yamashita of the University of Tokyo Hospital has established a distinguished research profile in radiation oncology through extensive peer-reviewed publications, international collaborations, and contributions to evidence-based clinical practice. His publication record, citation performance, and research influence reflect continued engagement in advancing oncological science and improving patient-centered radiotherapy approaches.[1]

Abstract

Hideomi Yamashita has developed an internationally recognized research portfolio in radiation oncology with emphasis on clinical radiotherapy, treatment optimization, cancer management, and translational medical research. His scholarly output demonstrates continuous scientific productivity supported by substantial citation performance and a strong h-index. These indicators illustrate sustained influence within oncology research and support recognition through the Best Researcher Award.[2]

Keywords

Radiation Oncology, Clinical Oncology, Radiotherapy, Cancer Research, Medical Physics, Precision Medicine, Oncology Research, Evidence-Based Medicine, Best Researcher Award, Academic Excellence

Introduction

Radiation oncology remains an essential discipline in modern cancer treatment through the integration of technological innovation, clinical evidence, and multidisciplinary patient care. Academic researchers contribute to improving treatment efficacy, reducing adverse effects, and supporting personalized therapeutic strategies. The scholarly activities of Hideomi Yamashita reflect these objectives through consistent publication, collaboration, and participation in advancing radiation oncology research.[3]

Research Profile

• Affiliation: University of Tokyo Hospital
• Country: Japan
• Research Area: Radiation Oncology
• Scopus Documents: 243
• Scopus Citations: 3,998
• h-index: 36

Research Contributions

The research contributions of Hideomi Yamashita include clinical investigations, radiation treatment planning, patient outcome evaluation, multidisciplinary oncology, and evidence-based therapeutic optimization. His publications have contributed to broader scientific understanding of radiotherapy practices while supporting improvements in clinical decision-making and patient management across oncology settings.[4]

Publications

• Clinical research articles in radiation oncology journals.
• Studies on radiotherapy treatment outcomes.
• Collaborative oncology research involving multidisciplinary clinical teams.
• Peer-reviewed publications indexed in Scopus and international scientific databases.

Research Impact

With 243 indexed publications, 3,998 citations, and an h-index of 36, the research profile demonstrates measurable academic influence within radiation oncology. Citation indicators suggest that the published work has contributed to ongoing scientific discussion and has been referenced by researchers working across cancer research, radiotherapy, and clinical medicine.

Award Suitability

The Best Researcher Award recognizes scholarly achievement through objective academic indicators together with sustained research quality and international scientific contribution. Hideomi Yamashita’s publication record, citation metrics, institutional affiliation, and continued engagement in oncology research align with the principles commonly considered in academic recognition programs.

Conclusion

Hideomi Yamashita has established a significant scholarly presence in radiation oncology through extensive peer-reviewed publications, sustained citation performance, and continued contributions to clinical cancer research. His academic profile illustrates long-term commitment to scientific advancement, interdisciplinary collaboration, and evidence-based healthcare, supporting recognition within international academic award programs.

External Links

• ORCID Profile
• Scopus Author Profile
• Award Website

References

1. 1. Scopus author details: Hideomi Yamashita, Author ID 9942829200.
      Scopus. https://www.scopus.com/pages/authors/9942829200
   2. ORCID.Hideomi Yamashita ORCID Record.
      https://orcid.org/0000-0001-9394-9490

   3. Safety and efficacy of moderately hypofractionated radiotherapy after radical prostatectomy: A phase II trial

      https://www.sciencedirect.com/science/article/pii/S0167814026003889
   4. International Research Award and Honors. Award Information.
      https://awardandhonors.com/